Clinical characteristics of dilated cardiomyopathy with pulmonary hypertension

被引:0
|
作者
Han, Bing [1 ,2 ,3 ]
机构
[1] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Shandong, Peoples R China
[2] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, State & Shandong Prov Joint Key Lab Translat Card, Jinan, Shandong, Peoples R China
[3] Sixth Peoples Hosp Jinan, Huiquan Rd 1920, Jinan, Shandong, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2018年 / 11卷 / 08期
关键词
Dilated cardiomyopathy; pulmonary hypertension; pulmonary artery systolic pressure; CELL DISTRIBUTION WIDTH; MEAN PLATELET VOLUME; DECOMPENSATED HEART-FAILURE; PROGNOSTIC VALUE; ENDOTHELIAL-CELLS; RENAL-FUNCTION; MORTALITY; DIAGNOSIS; DISEASE;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: The goal of this study was to evaluate the clinical characteristics of patients with dilated cardiomyopathy (DCM) with pulmonary hypertension (PH), to explore risk factors of patients with PH secondary to DCM. Methods: Two hundred and fifty DCM patients were retrospectively analyzed. The characteristics of basic clinical data, ultrasound index, biochemical index, RDW, and PDW were analyzed. Correlation between the above indexes and PASP or LVEF was investigated. Risk factors of PH secondary to DCM were analyzed by logistic regression analysis. Results: Length of medical history of the DCM-PH group (DCM with PH) was higher than that of the DCM group (DCM without PH), the percentage of patients with symptoms and signs of right heart failure of the DCM-PH group was higher than that of the DCM group (p<0.01). PASP was positively correlated with LAD, LVDd, RVDd, NT-proBNP, UA, Cr, and CYC, length of medical history, RAD, TBIL, RDW-SD, RDW-CV, PDW, P-LCR, MPV, were negatively correlated with LVEF and PA. LVEF was positively correlated with PA, negatively correlated with PASP, NT-proBNP, lengths of medical history, LAD, LVDd, RAD, RVDd, TBIL, UA, Cr, CYC, RDW-CV, and P-LCR. Conclusion: With increased PASP and decreased LVEF, the abnormality of ultrasound indexes, biochemical indexes, and RDW and PDW were more significant. Therefore, this study provides the basis of prevention, clinical diagnosis, and treatment for the occurrence of PH in patients with DCM.
引用
收藏
页码:8566 / 8575
页数:10
相关论文
共 50 条
  • [1] Clinical Characteristics and Outcome of Methamphetamine-Associated Pulmonary Arterial Hypertension and Dilated Cardiomyopathy
    Zhao, Susan X.
    Kwong, Calvin
    Swaminathan, Aravind
    Gohil, Amit
    Crawford, Michael H.
    JACC-HEART FAILURE, 2018, 6 (03) : 209 - 218
  • [2] A predictive model for dilated cardiomyopathy with pulmonary hypertension
    Liang, Jiahua
    Zhu, Ruochen
    Yang, Yi
    Li, Rong
    Hong, Chuangxiong
    Luo, Chuanjin
    ESC HEART FAILURE, 2021, 8 (05): : 4255 - 4264
  • [3] Relationships between pulmonary hypertension risk and clinical profile in dilated cardiomyopathy.
    Dziewiecka, E.
    Glimak, M.
    Winiarczyk, M.
    Karapetyan, A.
    Wisniowska-Smialek, S.
    Karabinowska, A.
    Holcman, K.
    Rubis, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 252 - 252
  • [4] Relationships between Pulmonary Hypertension Risk, Clinical Profiles, and Outcomes in Dilated Cardiomyopathy
    Dziewiecka, Ewa
    Wisniowska-Smialek, Sylwia
    Karabinowska, Aleksandra
    Holcman, Katarzyna
    Gliniak, Matylda
    Winiarczyk, Mateusz
    Karapetyan, Arman
    Kaciczak, Monika
    Podolec, Piotr
    Kostkiewicz, Magdalena
    Hlawaty, Marta
    Lesniak-Sobelga, Agata
    Rubis, Pawel
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)
  • [5] Does pulmonary hypertension impact clinical outcome or mortality in dilated cardiomyopathy patients?
    El Tahlawi, M. Mohammad
    Radwan, M.
    Abdelsamie, M.
    Wafaie, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 359 - 359
  • [6] Right ventricular phenotypic characteristics in subjects with primary pulmonary hypertension or idiopathic dilated cardiomyopathy
    Quaife, RA
    Lynch, D
    Badesch, DB
    Voelkel, NF
    Lowes, BD
    Robertson, AD
    Bristow, MR
    JOURNAL OF CARDIAC FAILURE, 1999, 5 (01) : 46 - 54
  • [7] Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension
    Dandel, Michael
    Wallukat, Gerd
    Englert, Angela
    Hetzer, Roland
    ATHEROSCLEROSIS SUPPLEMENTS, 2013, 14 (01) : 203 - 211
  • [8] Phenotype of patients with pulmonary hypertension as a complication of dilated cardiomyopathy
    Bauer, F.
    Kurtz, B.
    Vallet, C. H.
    Stepowski, D.
    D'here, B.
    Godin, M.
    Tron, C.
    Eltchaninoff, H.
    EUROPEAN HEART JOURNAL, 2011, 32 : 113 - 114
  • [9] The external respiration function in pulmonary hypertension at patients with dilated cardiomyopathy
    Akhmatov, Y. R.
    Abdullaev, T. A.
    Tsoy, A. Igor
    Bekbulatova, R. S. H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 591 - 591
  • [10] Familial dilated cardiomyopathy Clinical and genetic characteristics
    Serio, A.
    Narula, N.
    Kodama, T.
    Favalli, V.
    Arbustini, E.
    HERZ, 2012, 37 (08) : 822 - 829